Drugs / BGT007H Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06104215 | Oct 2023 → Oct 2026 expected | digestive system cancer | The Affiliated Hospital of Xuzhou Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BGT007H Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06104215 ↗ |
| Modality | Cell therapy | “BGT007H cell therapy” NCT06104215 ↗ |
| Route | Intravenous | “BGT007H injection (d0) were infused intravenously once” NCT06104215 ↗ |